November 26, 2012
Big Pharma Buys Influence in Science Journals
Peter Whoriskey, Washington Post
For drugmaker GlaxoSmithKline, the 17-page article in the New England Journal of Medicine represented a coup.
The 2006 report described a trial that compared three diabetes drugs and concluded that Avandia, the company’s new drug, performed best.
TAGGED: scientific journals, publication bias, pharmaceutical industry, Big Pharma